financetom
Business
financetom
/
Business
/
Eli Lilly says its diabetes drug tirzepatide gets approval in China
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eli Lilly says its diabetes drug tirzepatide gets approval in China
May 21, 2024 12:17 AM

SHANGHAI, May 21 (Reuters) - Eli Lilly ( LLY ) said on

Tuesday its tirzepatide drug has received approval from Chinese

regulators for use to treat type 2 diabetes.

Tirzepatide is the active ingredient in the U.S. firm's

diabetes drug Mounjaro and weight-loss drug Zepbound.

(Reporting by Andrew Silver; Editing by Muralikumar

Anantharaman)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved